155 related articles for article (PubMed ID: 1216091)
1. Immunologic enhancement in a syngeneic tumor system.
Beltz WR; Levy NL
Surg Forum; 1975; 26():142-4. PubMed ID: 1216091
[No Abstract] [Full Text] [Related]
2. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
Bendre AR; Gangal SG
Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
[No Abstract] [Full Text] [Related]
3. Immunologic enhancement induced by antibody fragments.
Cruse JM; Forbes JT; Gillespie GY; Lewis GK
Z Immunitatsforsch Allerg Klin Immunol; 1970; 140(3):259-67. PubMed ID: 4251393
[No Abstract] [Full Text] [Related]
4. The effect of tumor size on concomitant tumor immunity.
Deckers PJ; Davis RC; Parker GA; Mannick JA
Cancer Res; 1973 Jan; 33(1):33-9. PubMed ID: 4682321
[No Abstract] [Full Text] [Related]
5. Mechanisms of immunological enhancement.
Cruse JM; Lewis GK; Whitten HD; Watson ES; Fields JF; Adams ST; Harvey GF; Paslay JW; Porter M
Prog Exp Tumor Res; 1974; 19():110-56. PubMed ID: 4140539
[No Abstract] [Full Text] [Related]
6. Tumor facilitation in a syngeneic host-tumor system.
Cohen JM; Law LW
Proc Soc Exp Biol Med; 1974 Dec; 147(3):744-8. PubMed ID: 4374702
[No Abstract] [Full Text] [Related]
7. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
Rouse BT; Wagner H; Harris AW
J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
[No Abstract] [Full Text] [Related]
8. Effect of immunization of mice with syngeneic embryos on their ability to inhibit the growth of a challenging fibrosarcoma.
Ray PK; Seshadri M
Indian J Exp Biol; 1980 Sep; 18(9):1027-9. PubMed ID: 7203538
[No Abstract] [Full Text] [Related]
9. [Conditions of action of cytotoxic antibodies (fixing complement) in the rejection of tumoral homografts].
Callejas F; Kinsky RG; Voisin GA
Ann Inst Pasteur (Paris); 1972 Jul; 123(1):125-6. PubMed ID: 4640717
[No Abstract] [Full Text] [Related]
10. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells.
Zbar B; Canti G; Rapp HJ; Ashley MP; Sukumar S; Bast RC
Cancer Res; 1980 Apr; 40(4):1036-42. PubMed ID: 7357533
[No Abstract] [Full Text] [Related]
11. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
Jurin M; Suit HD
Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
[No Abstract] [Full Text] [Related]
12. [Immunostimulation of the growth of a syngeneic sarcoma primarily induced in mice by simian adenovirus SA7(C8)].
Ageenko AI; Erkhov VS
Vopr Onkol; 1977; 23(8):57-60. PubMed ID: 906408
[TBL] [Abstract][Full Text] [Related]
13. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
Weissman IL
J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
[No Abstract] [Full Text] [Related]
14. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
[TBL] [Abstract][Full Text] [Related]
15. Rejection of sarcoma cells at the site of an inflammatory reaction: macrophages are not the only effector cells.
Parr IB; Wheeler LE; Alexander P
Cancer Lett; 1975 Sep; 1(1):49-53. PubMed ID: 797442
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of heightened tumor immunity induced by cryosurgery.
Faraci RP; Bagley DH; Marrone JC; Ketcham AS; Beazley RM
Am Surg; 1975 May; 41(5):309-11. PubMed ID: 1130764
[TBL] [Abstract][Full Text] [Related]
17. Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue.
Vaage J
Cancer Res; 1971 Nov; 31(11):1655-62. PubMed ID: 5121668
[No Abstract] [Full Text] [Related]
18. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
McKenzie IF; Snell GD
Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
[No Abstract] [Full Text] [Related]
19. Increased growth of tumor isotransplants after immunosuppression of the recipient mice by methotrexate or 5-fluoro-2'-deoxyuridine.
Reiner J; Southam CM
J Natl Cancer Inst; 1967 May; 38(5):753-9. PubMed ID: 4225921
[No Abstract] [Full Text] [Related]
20. Circulating tumor antigens versus immune serum factors in depressed concomitant immunity.
Vaage J
Cancer Res; 1974 Nov; 34(11):2979-83. PubMed ID: 4425091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
